We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · October 22, 2020

Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration

JAMA Ophthalmology


Additional Info

JAMA Ophthalmology
Lifetime Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol 2020 Oct 15;[EPub Ahead of Print], RP Finger, M-T Puth, M Schmid, D Barthelmes, RH Guymer, M Gillies

Further Reading